Total Return chart Valerio Therapeutics

Stocks

Real-time Euronext Paris Other stock markets 11:11:42 13/07/2026 BST			5-day change	1st Jan Change
0.4210 ^EUR	-6.44%		-2.09%	+205.07%

06-30	Valerio Therapeutics Société anonyme signed a letter of intent to acquire eTheRNA immunotherapies NV for an enterprise value of ?30 million.	CI
06-17	Valerio Therapeutics Appoints New Chief Executive Officer

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.